ArticleBritish journal of cancer2025

Smad4 loss identifies aggressive subtype with immunotherapy and anti-HER-2 treatment resistance in gastric cancer.

Mengyao Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.